Literature DB >> 8731440

Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo.

Y Raphael1, J C Frisancho, B J Roessler.   

Abstract

Loss of ganglion cells is a common and irreversible complication of hair cell loss in the cochlea. Gene transfer could potentially be used to prevent this neuronal degeneration and other pathologies in the cochlea. Human adenoviruses should provide a feasible gene transfer vehicle for transducing the quiescent cochlear neurons and organ of Corti epithelium. We now describe in vivo experiments in which a replication-deficient adenoviral vector, Ad.RSVntlacZ was injected into the perilymphatic fluid of six normal guinea pigs. Postoperative recovery of animals was complete. Inner ear tissues were assessed for histology and for presence of lacZ-positive cells 1 or 2 weeks after the injection. A large number of blue (lacZ-positive) cells were observed in the neural, epithelial and connective tissues of the cochlea. In four ears spiral ganglion cell infection exceeded 50%, throughout the length of the cochlear spiral. No major pathology was detected in the organ of Corti and other cochlear tissues, and no infection was present in the vestibular tissues or the contralateral cochlea. Immunocytochemical assessment of T cells revealed an increased in the number of lymphocytes in the connective tissue lining the perilymphatic spaces. We conclude that efficient gene transfer into multiple types of cochlear cells in vivo can be achieved without major morphological signs of pathology or toxicity.

Entities:  

Mesh:

Year:  1996        PMID: 8731440     DOI: 10.1016/0304-3940(96)12499-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

1.  Engineering viral promoters for gene transfer to human neuroblasts.

Authors:  A Cara; E Lucarelli; P Cornaglia-Ferraris
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

2.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 3.  Local inner-ear drug delivery and pharmacokinetics.

Authors:  Alec N Salt; Stefan K R Plontke
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

Review 4.  [Protection and regeneration of sensory epithelia of the inner ear].

Authors:  S Pfannenstiel; M Praetorius
Journal:  HNO       Date:  2008-01       Impact factor: 1.284

Review 5.  Current status and prospects of gene therapy for the inner ear.

Authors:  Hong Sun; Aji Huang; Shousong Cao
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

6.  The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young rats.

Authors:  X Chen; X Zhao; Y Hu; F Lan; H Sun; G Fan; Y Sun; J Wu; W Kong; W Kong
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

Review 7.  Gene therapy for hearing loss.

Authors:  Ryotaro Omichi; Seiji B Shibata; Cynthia C Morton; Richard J H Smith
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 8.  Gene therapy in the inner ear using adenovirus vectors.

Authors:  Jacob Husseman; Yehoash Raphael
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

Review 9.  Therapeutic potential of neurotrophins for treatment of hearing loss.

Authors:  W Q Gao
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

10.  Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons.

Authors:  Jennifer A Chikar; Deborah J Colesa; Donald L Swiderski; Adriana Di Polo; Yehoash Raphael; Bryan E Pfingst
Journal:  Hear Res       Date:  2008-08-19       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.